Generic Sample Access Process For REMS-Protected Brands Now Includes Agency Timeline

US FDA has 120 days to review generic sponsors’ requests for letters to help them obtain product samples, but will not send them to the reference product company.

writting a letter
FDA has issued 60 Covered Product Authorization letters. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics